Plastic Surgery Scaffolds Market Size, Share & Industry Analysis, By Material (Bioabsorbable Polymers, Silk-derived Biomaterials, Others), By End User (Hospitals, Speciality Clinics, Others) And Regional Forecast, 2024-2032

Biologically-derived scaffolds are highly effective in tissue repair and regeneration. Owing to this property, they are now being extensively used in plastic surgey as well. During a breast surgery, scaffold is placed to support and reinforce the soft tissues during recovery. This initiates the natual healing process after surgery. Advantages of scaffold and new product launches are key factors boosting the market. For instance, in April 2017, Galatea Surgical received FDA 510k clearance for GalaFORM 3D Surgical Scaffold for use in reconstructive and plastic surgery. Furthermore, with the increasing trend for cosmetic srugeries, the demand for plastic surgery scaffolds is also increasing.

Growing inclination towards aesthetic procedures especially among women, has led to increase in number of breast surgeries across the globe. According to the American Society of Plastic Surgeons, a total of 299,715 breast augmentation procedures were performed in the U.S. in 2019. This, coupled with introduction of scaffolds for breast surgery that can heal naturally are expected to drive the market growth. Apart from this, increasing awareness regarding the benefits of surgical scaffolds among patient population are likely to favor the market expansion. 

However, plastic surgeries are not considered as a medical condition or emergencies by the insurance providers. Thus, poor reimbursement for plastic surgeries are a major factor hampering the growth of market.

Market Segmentation:

Globally, the plastic surgery scaffolds market can be categorized on the basis of material, end user, and region. On the basis of material, the market can be segmented into bioabsorbable polymers, silk-derived biomaterials, and others. In terms of end users, the market can ne bifurcated into hospitals, specialty clinics, and others.

Geographically, the plastic surgery scaffolds market can be segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa.

Key Players Covered:

Some of the major companies that are present in the plastic surgery scaffolds market are Sofregen Medical Inc., BellaSeno GmbH, Osteopore International Pte Ltd, Galatea Surgical, Integra LifeSciences Corporation, MTF Biologics, and others.

Key Insights:

• Number of Key Cosmetic Procedures – For Key Countries


• New Product Launches by Key Players


• Key Industry Trends


• Key Industry Developments – Merger, Acquisitions, and Partnerships


• Technological Advancements in Plastic Surgery Scaffolds


• COVID-19 Impact on Plastic Surgery Scaffolds Market

Regional Analysis:

Based on segmentation of geography, the plastic surgery scaffolds market can be segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is anticipated to dominate the market throughout the forecast period. This can be attributed to the increasing demand for breast augmentation and strategic presence of key market players. According to the International Society of Aesthetic Plastic Surgery (ISAPS) survey of 2018, the highest number of aesthetic procedures are performed in the U.S., Brazil, and Mexico. This is projected to foster the market in North America and Latin America.

On the other hand, the market in Europe and Aisa Pacific is poised surge owing to the rising awareness about scaffolds and increasing spending capacity of the population. According to the British Association of Aesthetic Plastic Surgeons (BAAPS), around 6,900 breast procedures were performed in the U.K. in 2019. This, in-turn is expected to boost the market in Europe.

Segmentation

Plastic Surgery Scaffolds Market Industry Developments

• In April 2017, Galatea Surgical received FDA 510k clearance for GalaFORM 3D Surgical Scaffold for use in reconstructive and plastic surgery.


• In October 2017, Integra LifeSciences Corporation announced the launch of Integra SurgiMend PRS Meshed in Europe for reconstructive and plastic surgery including breast reconstruction.